National Taiwan University Honors Chiou with Distinguished Alumni Achievement Award
TAMHSC
COM
OIA
Communications
News
2005 News Archive
National Taiwan University Honors Chiou with Distinguished Alumni Achievement Award
Dr. Chiou was visiting the university last week to give a lecture and was presented the award in a surprise ceremony after his talk. He attended National Taiwan University from 1953-1957 and received his bachelor’s degree in pharmacy.
Dr. Chiou’s primary research focuses on ocular medicine and treatment. His major scientific breakthrough was the discovery of timolol, a medication for the treatment of glaucoma. Timolol was introduced to the market in 1978 and has since been used by more than 100 million glaucoma patients. Currently, Dr. Chiou is working on treatment for age-related macular degeneration (AMD).
The founder and chief editor of the Journal of Ocular Pharmacology and Therapeutics, Dr. Chiou has published a book and authored or co-authored more than 230 publications. He has trained eight Ph.D. students and 35 post doctoral fellows and/or visiting scholars from around the world. In addition to his position at the A&M College of Medicine, Dr. Chiou is an honorary professor at China Academy of Traditional Chinese Medicine (TCM), Nanjing Medical University of TCM, China Pharmaceutical University, Nanjing Institute of Materia Medica and Nanjing Medical University in China.
Dr. Chiou received his Ph.D. in pharmacology from Vanderbilt University in 1967 and completed his postdoctoral research in autonomic pharmacology at the University of Iowa Medical School. He has been has been a department head since his arrival at the A&M College of Medicine in 1978.

